Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 601 AL 615

Human prion diseases: molecular, cellular and population biology

Head MW.

Neuropathology. 2013 Jun;33(3):221-36. doi: 10.1111/neup.12016. Epub 2013 Jan 20.

Relearning of writing skills in Parkinson's disease: a literature review on influential factors and optimal strategies

Nackaerts E, Vervoort G, Heremans E, Smits-Engelsman BC, Swinnen SP, Nieuwboer A.

Neurosci Biobehav Rev. 2013 Mar;37(3):349-57. doi: 10.1016/j.neubiorev.2013.01.015. Epub 2013 Jan 16.

Glutathione and thioredoxin dependent systems in neurodegenerative disease: what can be learned from reverse genetics in mice

Conrad M, Schick J, Angeli JP.

Neurochem Int. 2013 Apr;62(5):738-49. doi: 10.1016/j.neuint.2013.01.010. Epub 2013 Jan 18.

Dysphagia in Parkinson's disease is responsive to levodopa

Sutton JP.

Parkinsonism Relat Disord. 2013 Mar;19(3):282-4. doi: 10.1016/j.parkreldis.2012.11.007. Epub 2013 Jan 18.

Gait dysfunction in Parkinson's disease and normal pressure hydrocephalus: a comparative study

Bugalho P, Alves L, Miguel R.

J Neural Transm (Vienna). 2013 Aug;120(8):1201-7. doi: 10.1007/s00702-013-0975-3. Epub 2013 Jan 20.

[Hormonal imprinting in the central nervous system: causes and consequences]

Csaba G.

Orv Hetil. 2013 Jan 27;154(4):128-35. doi: 10.1556/OH.2013.29533.

Review: the role of vitamin D in nervous system health and disease

DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):458-84. doi: 10.1111/nan.12020.

New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease

Vazey EM, Aston-Jones G.

Brain Res. 2013 May 20;1511:153-63. doi: 10.1016/j.brainres.2013.01.021. Epub 2013 Jan 18.

Use of imaging to study leukocyte trafficking in the central nervous system

Zenaro E, Rossi B, Angiari S, Constantin G.

Immunol Cell Biol. 2013 Apr;91(4):271-80. doi: 10.1038/icb.2012.81. Epub 2013 Jan 22.

From bench to bed: putative animal models of REM sleep behavior disorder (RBD)

Krenzer M, Lu J, Mayer G, Oertel W.

J Neural Transm (Vienna). 2013 Apr;120(4):683-8. doi: 10.1007/s00702-012-0965-x. Epub 2013 Jan 22.

Sleep and non-motor symptoms in Parkinson's disease

Maass A, Reichmann H.

J Neural Transm (Vienna). 2013 Apr;120(4):565-9. doi: 10.1007/s00702-013-0966-4. Epub 2013 Jan 22.

Benign tremulous Parkinson's disease: a misnomer?

Deuschl G.

Mov Disord. 2013 Feb;28(2):117-9. doi: 10.1002/mds.25317. Epub 2013 Jan 21.

Caffeine consumption and risk of dyskinesia in CALM-PD

Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA; Parkinson Study Group.

Mov Disord. 2013 Mar;28(3):380-3. doi: 10.1002/mds.25319. Epub 2013 Jan 21.

Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy

Kluger BM, Krupp LB, Enoka RM.

Neurology. 2013 Jan 22;80(4):409-16. doi: 10.1212/WNL.0b013e31827f07be.

Review: microglia in protein aggregation disorders: friend or foe?

Gentleman SM.

Neuropathol Appl Neurobiol. 2013 Feb;39(1):45-50. doi: 10.1111/nan.12017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias